Personalising pancreas cancer treatment: When tissue is the issue

The treatment of advanced pancreatic cancer has not moved much beyond single agent gemcitabine until recently when protocols such as FOLFIRINOX (fluorouracil, leucovorin, irinotecan and oxaliplatin) and nab-paclitaxel-gemcitabine have demonstrated some improved outcomes. Advances in technology espec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sjoquist, Katrin M, Chin, Venessa T, Chantrill, Lorraine A, O’Connor, Chelsie, Hemmings, Chris, Chang, David K, Chou, Angela, Pajic, Marina, Johns, Amber L, Nagrial, Adnan M, Biankin, Andrew V, Yip, Desmond
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Inc 2014
Schlagworte:
Topic Highlight
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069313/
https://ncbi.nlm.nih.gov/pubmed/24976722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7849
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge